Results 21 to 30 of about 2,327,584 (298)

Brain malignancies: Glioblastoma and brain metastases

open access: yesSeminars in Cancer Biology, 2020
Brain, the major organ of the central nervous system controls and processes most of body activities. Therefore, the most aggressive brain tumor - glioblastoma and metastases from other organs to the brain are lethal leaving the patients with very short time of survival.
Lah Turnšek, Tamara   +2 more
openaire   +3 more sources

The role of brachytherapy in the management of brain metastases: a systematic review

open access: yes, 2020
© 2020 Termedia Publishing House Ltd.. All rights reserved. Purpose: Brain metastases have a highly variable prognosis depending on the primary tumor and associated prognostic factors.
Sarfaraz, Mehrdad   +7 more
core   +1 more source

Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma

open access: yesCancer Medicine, 2021
Background Novel treatments make long‐term survival possible for subsets of patients with melanoma brain metastases. Brain magnetic resonance imaging (MRI) may aid in early detection of brain metastases and inform treatment decisions. This study aimed to
Annemarie C. Eggen   +7 more
doaj   +1 more source

Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)

open access: yesOncoImmunology, 2022
Lung cancer is one of the most common causes of brain metastases and is always associated with poor prognosis. We investigated the immunophenotypes of primary lung tumors and paired brain metastases, as well as immunophenotypes in the synchronous group ...
Meichen Li   +11 more
doaj   +1 more source

Treatment of brain metastases [PDF]

open access: yesBiomedical Papers, 2016
Brain metastases are a very common neurological sequela in cancer patients. The ability of current anti-cancer therapies to prolong overall survival is beleaguered by this development in the case of a number of different cancers. This review provides a general overview of relevant treatment modalities, highlights major decision strategies used in ...
Marcel Matzenauer   +2 more
openaire   +3 more sources

Glecirasib treatment in KRAS G12C-positive non-small cell lung cancer with leptomeningeal metastasis

open access: yesFrontiers in Oncology
BackgroundLeptomeningeal metastasis (LM) is associated with poor outcomes in non-small cell lung cancer (NSCLC), and clinical evidence for KRAS G12C inhibition in this setting is limited.
Yunfei Li   +9 more
doaj   +1 more source

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial

open access: yesTrials, 2022
Background This study is in regard to the comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the
Xiaofang Zhang   +6 more
doaj   +1 more source

Artificial Intelligence, Multi-Omics, and Multimodal Integration in Precision Radiotherapy for Head and Neck Cancer: From Biological Insights to Treatment Decisions

open access: yesBiomedicines
Radiotherapy for head and neck cancer must balance disease control against normal-tissue injury. Artificial intelligence (AI), multi-omics, and multimodal analysis offer complementary ways to characterize tumor and host heterogeneity, but their relevance
Miao Rao   +3 more
doaj   +1 more source

Dynamic contrast‐enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases

open access: yesCancer Medicine, 2017
Brain metastases originating from different primary sites overlap in appearance and are difficult to differentiate with conventional MRI. Dynamic contrast‐enhanced (DCE)‐MRI can assess tumor microvasculature and has demonstrated utility in characterizing
Vaios Hatzoglou   +7 more
doaj   +1 more source

Patient survival outcomes in brain metastases of pancreatic ductal adenocarcinoma: A comprehensive analysis

open access: yesCancer Treatment and Research Communications
s: Background: Pancreatic ductal adenocarcinoma (PDAC) often presents with metastases. Brain metastases are rare, necessitating a thorough analysis of patient profiles and management.
Yuanchi Ma   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy